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Background
The discovery of broadly neutralizing antibodies (bnAbs)
such as 4E10, pg9 and VRC01 binding to the HIV env
spike has electrified the field and shows that, in principle,
the human immune system is capable of producing pro-
tective antibodies against HIV. All current vaccination
strategies have however failed to elicit such bnAbs, leaving
room for novel approaches to address this problem.
Protein engineering techniques such as yeast surface dis-
play have proven potential for the discovery and affinity
maturation of monoclonal antibodies. Antibody libraries
are presented on yeast cells and flow cytometric sorting is
used to identify antibody variants with improved proper-
ties. As antibodies, also HIV env spikes are posttransla-
tionally modified in the secretory pathway and composed
of disulphide bond-containing glycoproteins. We here
investigated whether HIV spike protein variants can be
displayed or secreted from surface of the yeast strain S.
cerevisiae.
Methods
A panel of HIV env spike protein-encoding genes was
inserted in vectors allowing for the display or secretion of
the encoded proteins in S. cerevisiae. The displayed pro-
tein variants were analyzed for binding to either bnAbs or
pooled HIV immunoglobulin from the serum of infected
individuals (HIVIg) using flow cytometry. The secreted
protein variants were tested for binding activities on an
Octet biosensor.
Results
We found that HIV env spike protein variants can be
displayed or secreted from the yeast strain S. cerevisiae.
Both displayed and secreted variants showed binding to
bnAbs and HIVIg.
Conclusion
This study suggests that yeast surface display is as a viable
option for the engineering of HIV env spike protein var-
iants and may become a valuable tool for the discovery of
novel vaccine immunogens.
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